Streetbeat News

Regulatory

NMR

Komainu, a joint cryptocurrency custody venture involving Nomura (NYSE:NMR), Ledger and CoinShares, has been granted an operating license by Dubai's Virtual Asset Regulatory Authority (VARA). This license allows Komainu to extend its custody services, including institutional staking and collateral management, to clients within Dubai through its Komainu Connect platform. Other significant players, such as Laser Digital, a digital asset subsidiary of Nomura, and Binance, have also recently secured operating licenses from VARA.

Portfolio Pulse from Murtuza Merchant

August 22, 2023 | 9:44 pm

WMT

Walmart has announced that its state settlement framework will become effective on September 6, 2023. The company will pay the remaining $2.8 billion of the original $3.3 billion accrued liability in Q3 of FY24, according to a filing.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 9:08 pm

QCOM

The Federal authorities are investigating a deal by Qualcomm (QCOM) involving microchips for autonomous cars. The deal is said to bring Qualcomm back into the spotlight after it faced scrutiny over its patent licensing practices.

Portfolio Pulse from Charles Gross

August 22, 2023 | 9:07 pm

DUK

Duke Energy Carolinas has entered a partial agreement with North Carolina Public Staff to enhance system reliability and reduce the requested rate increase. The agreement is subject to approval by the North Carolina Utilities Commission.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 9:00 pm

CURO

CURO Group Holdings Corp. has received a notice of complaint from the Consumer Financial Protection Bureau (CFPB) regarding certain small loans originated by Heights Finance's subsidiaries. These small loans represent less than 15% of CURO's Direct Lending portfolio as of June 30, 2023.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 8:57 pm

REGN

Regeneron Pharmaceuticals Inc has been awarded a government contract valued at up to $326 million by the Biomedical Advanced Research and Development Authority (BARDA) for the development of new vaccines and therapeutics against COVID-19. The U.S. Department of Health and Human Services (HHS) will fund up to 70% of Regeneron's costs. This falls under Regeneron and BARDA's ongoing agreement from 2017 to develop a portfolio of antibodies targeting up to 10 pathogens that pose a significant public health risk.

Portfolio Pulse from Adam Eckert

August 22, 2023 | 8:43 pm

FMC

FMC Corporation (NYSE:FMC) has received Brazilian registration for its broad-spectrum fungicide, fluindapyr. The fungicide provides preventative control of various diseases prevalent in Brazilian row crops. FMC plans to register several fluindapyr formulations in Brazil for use in cotton, corn, and soybean. The registration in Brazil marks another significant regulatory approval for FMC and fluindapyr, which is already registered in Argentina, the United States, Paraguay, and South Korea.

Portfolio Pulse from Happy Mohamed

August 22, 2023 | 8:34 pm

BMY

Bristol Myers Squibb has received approval from the European Commission for Opdivo, a treatment for patients with completely resected stage IIB or IIC melanoma.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 8:18 pm

UONE

UONEK

Urban One, Inc. (NASDAQ:UONEK, UONE) has received a third notification from NASDAQ for non-compliance with Listing Rule 5250(c)(1) due to not having timely filed its Q1 and Q2 2023 Form 10-Q. The company has until September 27, 2023, to regain compliance or face potential delisting. The company plans to file both the Q1 and Q2 2023 Form 10-Q on or before the deadline.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 8:17 pm

COMS

COMSovereign has received a notice from Nasdaq regarding a delay in its quarterly report. The company is expected to submit the report soon to avoid any potential penalties.

Portfolio Pulse from Benzinga Newsdesk

August 22, 2023 | 8:16 pm